Cargando…
Assessment of Ocriplasmin Effects on the Vitreoretinal Compartment in Porcine and Human Model Systems
Ocriplasmin (Jetrea®) is a recombinant protease used to treat vitreomacular traction. To gain insight into vitreoretinal observations reported after ocriplasmin treatment, we have developed an in vivo porcine ocriplasmin-induced posterior vitreous detachment (PVD) model in which we investigated vitr...
Autores principales: | Jonckx, Bart, Porcu, Michael, Candi, Aurelie, Etienne, Isabelle, Barbeaux, Philippe, Feyen, Jean H. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682056/ https://www.ncbi.nlm.nih.gov/pubmed/29214073 http://dx.doi.org/10.1155/2017/2060765 |
Ejemplares similares
-
Ocriplasmin for Vitreoretinal Diseases
por: Tsui, Irena, et al.
Publicado: (2012) -
Release of experimental retinal vein occlusions by direct intraluminal injection of ocriplasmin
por: de Smet, Marc D, et al.
Publicado: (2016) -
Assessment of E. coli Expression System for Overexpression of Active Recombinant Ocriplasmin
por: Baghban, Roghayyeh, et al.
Publicado: (2021) -
Ocriplasmin: who is the best candidate?
por: Prospero Ponce, Claudia M, et al.
Publicado: (2016) -
Retinal breaks due to intravitreal ocriplasmin
por: Silva, Ruwan A, et al.
Publicado: (2014)